_1777352142843_145525226.png&w=48&q=75){kind=small}
Drug Authority halts popular stomach medication
The Egyptian Drug Authority has issued a warning regarding unidentified packaging of the medication "Patrimac Rabeprazole Sodium 20 mg" and has halted the circulation and use of the product "Perloc 40 mg" after it was confirmed that they do not meet specifications. "Patrimac" is used to treat acid reflux and stomach ulcers, while "Perloc" is administered to patients who are unable to take medication orally, in cases of severe ulcers, acid reflux, and gastrointestinal bleeding. This decision is part of the Authority's efforts to ensure drug safety and protect patients, with instructions to pharmacies and healthcare institutions not to circulate unapproved packages and to report any packaging suspected of non-compliance.
Notice: This Is an AI-Generated Summary
Comments (0)